Licensing Opportunity:
Recombinant Vaccines Based on Poxviruses
This technology offers a method of constructing recombinant vaccines by using any recombinant poxvirus as a backbone that carries a foreign DNA. The technology takes advantage of the unique properties of poxviruses as a delivering vehicle and of the ease of preparation of such constructs. It can be applied to produce potential vaccines, for immunotherapy, and for other applications. Read more about this licensing opportunity:https://www.ott.nih.gov/
.png)
No hay comentarios:
Publicar un comentario